CUDC-101 is a potent multi-acting HDAC (histone deacetylase), EGFR (epidermal growth factor receptor), and HER2 ( human epidermal growth factor receptor 2) inhibitor for the treatment of cancer.
Molecular Spectra
No Data Available
Click here to submit data
References
• Bali, P., et al.: Clin. Cancer Res., 11, 6382 (2005)